Skip to Main Content

Immediate Pause in the Administration of the Johnson and Johnson COVID-19 vaccine


The FDA is recommending an immediate pause in the administration of the Johnson and Johnson (Janssen) COVID-19 vaccine due reports of six cases of a rare and serious clot (cerebral venous sinus thrombosis)…there has been one associated death…for context, 6.8 million doses of the Johnson and Johnson COVID-19 vaccine have been administered…a link to the FDA statement is below.

Consequently, all CommonSpirit Health facilities should immediately halt administration of the Johnson and Johnson COVID-19 vaccine…there will be an emergency session of the Advisory Committee on Immunization Practices (ACIP) tomorrow (Wednesday, April 14) to review the data…additional guidance might be forthcoming after ACIP meets.

Please be sure all of your sites are aware of this development…our pharmacy and patient safety teams are working to provide additional information today.

Read the full story at the FDA Website.

Publish date: 

Wednesday, April 14, 2021

News

CommonSpirit Health Announces FY2022 Year End Results

SEP 23, 2022

CommonSpirit Health has released financial results for its 2022 fiscal year, which ended June 30.

Read More Additional information about CommonSpirit Health Announces FY2022 Year End Results

5 Questions About the Updated Bivalent Booster

SEP 22, 2022

Dr. Thomas McGinn, EVP, Physician Enterprise, answers five common questions about the updated bivalent booster vaccine to protect against COVID-19.

Read More Additional information about 5 Questions About the Updated Bivalent Booster